CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Chaudhuri Sarbani See Remarks | Sale | −4,872 | $2.33 | $11K | 257,937 |
| 2026-11-05 | Wilson Martin General Counsel | Sale | −53,389 | $2.39 | $128K | 545,100 |
| 2026-09-11 | Wilson Martin General Counsel | Sale | −75,364 | $3.40 | $256K | 598,489 |
| 2026-08-18 | Wilson Martin General Counsel | Sale | −631 | $3.38 | $2K | 673,853 |
| 2026-08-18 | Shah Gaurav CEO | Sale | −2,293 | $3.38 | $8K | 1,056,594 |
| 2026-08-13 | Shah Gaurav CEO | Sale | −2,837 | $3.38 | $10K | 1,058,887 |
| 2026-08-13 | Wilson Martin General Counsel | Sale | −3,493 | $3.38 | $12K | 674,484 |
| 2026-08-11 | Stevens Christopher James Chief Operating Officer | Sale | −36,658 | $3.50 | $128K | 505,784 |
| 2026-08-11 | Chaudhuri Sarbani See Remarks | Sale | −4,701 | $3.50 | $16K | 262,809 |
| 2026-08-03 | Stevens Christopher James Chief Operating Officer | Grant or award | +73,313 | 542,442 | ||
| 2026-08-03 | Stevens Christopher James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +101,428 | 101,428 | ||
| 2026-08-03 | SOUTHWELL DAVID P Director | Other acquisition | +150,000 | 204,522 | ||
| 2026-06-18 | WONG RODERICK Director | Grant or award | +27,832 | 75,499 | ||
| 2026-06-18 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +78,960 | 78,960 | ||
| 2026-06-18 | Fong Peter Director | Grant or award | +22,862 | 76,195 | ||
| 2026-06-18 | Fong Peter Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 | ||
| 2026-06-18 | Dolsten Mikael Director | Grant or award | +22,862 | 67,082 | ||
| 2026-06-18 | Dolsten Mikael Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 | ||
| 2026-06-18 | Malik Fady Ibraham Director | Grant or award | +22,862 | 52,862 | ||
| 2026-06-18 | Malik Fady Ibraham Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 |
Page 1 of 9 · 164 trades